Principia Biopharma Inc (PRNB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

220 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080

Principia Biopharma Inc. operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States.

Data based on most recent fiscal year report
Market Cap1.977 Billion Shares Outstanding32.79 Million Avg Volume232.599 Thousand
1-Yr BETA vs S&P TR0.922 Current Ratio10.71 Quick Ratio10.71
View SEC Filings from PRNB instead.

View recent insider trading info

Funds Holding PRNB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRNB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

39 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

19 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

  • 10% Owner
25,913,539 2020-03-23 1

THOMPSON PETER A.

  • Director
  • 10% Owner
6,767,584 2020-03-19 0

WOLFF STEFANI CHIEF DEVELOPMENT OFFICER

  • Officer
35,609 2020-03-16 3

HARDIMAN ROY C. CHIEF BUSINESS OFFICER

  • Officer
118,819 2020-03-13 4

USMAN NASSIM PRESIDENT & CEO

  • Officer
  • Director
20,634 2020-03-13 0

CHAI CHRISTOPHER Y CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-05 2

GOLDSTEIN DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-03-05 3

THOMAS DOLCA CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-05 2

BABLER MARTIN PRESIDENT, CEO

  • Officer
  • Director
39,179 2020-03-03 3

SMITHER JOHN W CHIEF FINANCIAL OFFICER

  • Officer
  • Director
108,965 2020-02-27 0

TOMASELLO SHAWN

  • Director
0 2020-02-10 3

LIN SHAO-LEE EVP, HEAD OF R&D AND CSO

  • Officer
109,668 2020-01-21 3

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 2

MACHADO PATRICK

  • Director
0 2020-01-01 2

AKKARAJU SRINIVAS

  • Director
607,881 2019-12-02 0

BECKER DANIEL J.

  • Director
667,600 2019-11-20 4

GEORGE SIMEON

  • Director
2,982,855 2019-10-18 2

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.

NEW LEAF BPO ASSOCIATES II, L.P.

NEW LEAF BPO MANAGEMENT II, L.L.C

  • 10% Owner
2,325,713 2019-08-13 1

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
4,685,574 2019-07-01 0

COLOWICK ALAN

  • Director
0 2019-06-19 1

MORGENTHALER VENTURE PARTNERS IX LP

MORGENTHALER MANAGEMENT PARTNERS IX, LLC

  • 10% Owner
No longer subject to file 2018-11-16 0

GOURLAY STEVE CHIEF MEDICAL OFFICER

  • Officer
107,857 2018-09-18 0

SOFINNOVA VENTURE PARTNERS VIII, L.P.

SOFINNOVA MANAGEMENT VIII, L.L.C.

HEALY JAMES

POWELL MICHAEL

MEHRA ANAND

  • 10% Owner
2,038,208 2018-09-18 0

SHUSTER LEWIS

  • Director
0 2018-09-13 0

SHUSTER LEWIS

SHUSTER LEWIS

  • Director
0 2018-09-13 0

AKKARAJU SRINIVAS

AKKARAJU SRINIVAS

  • Director
0 2018-09-13 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WOLFF STEFANI - Officer CHIEF DEVELOPMENT OFFICER

2020-03-16 M 5,504 d 19,047 35,609.00 direct

WOLFF STEFANI - Officer CHIEF DEVELOPMENT OFFICER

2020-03-16 M 5,504 $4.54 a 41,113 35,609.00 direct

WOLFF STEFANI - Officer CHIEF DEVELOPMENT OFFICER

2020-03-16 S 3,750 $46.36 d 35,609 35,609.00 direct yes

WOLFF STEFANI - Officer CHIEF DEVELOPMENT OFFICER

2020-03-16 S 1,754 $45.72 d 39,359 35,609.00 direct yes

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-13 S 1,181 $49.46 d 117,003 118,819.00 direct yes

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-13 M 5,000 d 7,758 118,819.00 direct

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-13 S 3,719 $48.21 d 118,184 118,819.00 direct yes

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-13 S 100 $51.04 d 116,903 118,819.00 direct yes

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-13 M 5,000 $4.72 a 121,903 118,819.00 direct

WOLFF STEFANI - Officer CHIEF DEVELOPMENT OFFICER

2020-03-05 A 55,000 a 55,000 0.00 direct

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-03-05 A 55,000 a 55,000 0.00 direct

THOMAS DOLCA - Officer CHIEF MEDICAL OFFICER

2020-03-05 A 55,000 a 55,000 0.00 direct

GOLDSTEIN DAVID - Officer CHIEF SCIENTIFIC OFFICER

2020-03-05 A 75,000 a 75,000 0.00 direct

HARDIMAN ROY C. - Officer CHIEF BUSINESS OFFICER

2020-03-05 A 55,000 a 55,000 0.00 direct

BABLER MARTIN - Director - Officer PRESIDENT, CEO

2020-03-05 A 200,000 a 200,000 39,179.00 direct

BABLER MARTIN - Director - Officer PRESIDENT, CEO see footnote

2020-03-03 S 300 $64.83 d 39,179 39,179.00 indirect yes

BABLER MARTIN - Director - Officer PRESIDENT, CEO see footnote

2020-03-03 S 2,085 $62.45 d 52,094 39,179.00 indirect yes

BABLER MARTIN - Director - Officer PRESIDENT, CEO see footnote

2020-03-03 S 5,432 $64.10 d 39,479 39,179.00 indirect yes

BABLER MARTIN - Director - Officer PRESIDENT, CEO see footnote

2020-03-03 S 7,183 $63.24 d 44,911 39,179.00 indirect yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 M 2,500 d 70,157 8,068.00 direct

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 605 $67.08 d 7,082 8,068.00 direct yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 2,684 $63.86 d 9,582 8,068.00 direct yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 76 $68.52 d 4,766 8,068.00 direct yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 1,350 $65.94 d 7,687 8,068.00 direct yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 M 2,500 $3.00 a 12,266 8,068.00 direct

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 2,240 $68.13 d 4,842 8,068.00 direct yes

CHAI CHRISTOPHER Y - Officer CHIEF FINANCIAL OFFICER

2020-02-18 S 545 $64.91 d 9,037 8,068.00 direct yes

GOLDSTEIN DAVID - Officer CHIEF SCIENTIFIC OFFICER

2020-02-10 M 6,000 $3.00 a 36,968 30,968.00 direct

GOLDSTEIN DAVID - Officer CHIEF SCIENTIFIC OFFICER

2020-02-10 S 5,200 $71.11 d 30,968 30,968.00 direct yes

BABLER MARTIN - Director - Officer PRESIDENT, CEO see footnote

2020-02-10 G 1,159 a 18,355 39,179.00 indirect

GOLDSTEIN DAVID - Officer CHIEF SCIENTIFIC OFFICER

2020-02-10 S 800 $69.53 d 36,168 30,968.00 direct yes

BABLER MARTIN - Director - Officer PRESIDENT, CEO

2020-02-10 G 1,159 d 0 39,179.00 direct

GOLDSTEIN DAVID - Officer CHIEF SCIENTIFIC OFFICER

2020-02-10 M 6,000 d 8,447 30,968.00 direct

Elevate your investments